Michelle Renee Griffin
Director · Adaptive Biotechnologies Corp
- 2026
- Jun 29, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michelle Renee Griffin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michelle Renee Griffin?
Michelle Renee Griffin is a corporate insider, tracked as Director of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michelle Renee Griffin last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 4 filings going back to 2026.
Has Michelle Renee Griffin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($2.00M) across all tracked filings.
